01 1Concord Biotech
01 1ROMIDEPSIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-15
Pay. Date : 2013-10-25
DMF Number : 27399
Submission : 2013-11-01
Status : Active
Type : II
20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ROMIDEPSIN, with a corresponding US DMF Number 27399.
Remarkably, this DMF maintains an Active status since its submission on November 01, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 15, 2014, and payment made on October 25, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
